XML 18 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Aug. 27, 2022
Aug. 28, 2021
Operating activities:    
Net loss $ (441,481) $ (113,358)
Adjustments to reconcile to net cash (used in) provided by operating activities:    
Depreciation and amortization 138,637 149,718
Facility exit and impairment charges 112,416 20,184
Goodwill and intangible asset impairment charges 252,200
LIFO charge (credit) 10,121 (7,986)
(Gain) loss on sale of assets, net (58,197) 5,820
Change in allowances for uncollectible accounts receivable (1,671)
Stock-based compensation expense 8,069 8,603
(Gain) loss on debt modifications and retirements, net (41,312) 3,235
Changes in deferred taxes 6,133
Changes in operating assets and liabilities:    
Accounts receivable (211,673) (212,855)
Inventories (77,405) (19,096)
Accounts payable (43,343) 91,324
Operating lease right-of-use assets and operating lease liabilities (31,713) (12,309)
Other assets (10,870) 25,185
Other liabilities (61,372) 101,133
Net cash (used in) provided by operating activities (451,461) 39,598
Investing activities:    
Payments for property, plant and equipment (122,243) (105,356)
Intangible assets acquired (15,356) (14,479)
Proceeds from insured loss 10,436
Proceeds from dispositions of assets and investments 41,003 4,676
Proceeds from sale-leaseback transactions 45,986 14,185
Net cash used in investing activities (50,610) (90,538)
Financing activities:    
Proceeds from issuance of long-term debt 350,000
Net proceeds from revolver 677,000 250,000
Principal payments on long-term debt (152,011) (542,988)
Change in zero balance cash accounts (12,931) (844)
Financing fees paid for early debt redemption (881) (833)
Payments for taxes related to net share settlement of equity awards (2,019) (2,221)
Deferred financing costs paid (16,512)
Net cash provided by financing activities 509,158 36,602
Increase (decrease) in cash and cash equivalents 7,087 (14,338)
Cash and cash equivalents, beginning of period 39,721 160,902
Cash and cash equivalents, end of period $ 46,808 $ 146,564